Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR
- PMID: 37702371
- DOI: 10.1002/cyto.b.22142
Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR
Abstract
Background: Monocyte (m)HLA-DR expression appears to be a potent marker of immunosuppression in critically ill patients. The persistence of low mHLA-DR expression is associated with an increased risk of nosocomial infections and mortality. To adapt this measurement to pediatric requirements and provide extensive 24/7 access, we have developed a whole blood no-lyse no-wash micromethod (MM) and compared it with the standardized method (SM).
Methods: mHLA-DR was quantified by flow cytometry using Quantibrite™ Anti-HLA-DR PE/Monocyte PerCP-Cy™5.5 with either the SM performed in a diagnostic hematology laboratory using manufacturer protocol, or a whole blood no-lyse no-wash MM using an Attune flow cytometer located in the pediatric ICU. Median fluorescence intensity was measured in both techniques and converted to antibodies per cell (AB/C) calibrated with BD Quantibrite™ PE beads. Blood and Quantibrite™ reagent volume used with the MM was reduced by 5-fold compared to SM. In addition to Quantibrite™ Anti-Human HLA-DR PE/Monocyte PerCP-Cy™5.5, MM required anti-CD45 and anti-CD19 labeling.
Results: We determined the expression of mHLA-DR in 34 patients, 20 adults, and 14 children admitted to ICU. Correlation between MM and SM was excellent (Pearson's correlation: y = 0.8192x + 678.7, r = 0.9270, p < 0.0001). The estimated bias was 2467 ± 1.96 × 3307 AB/C; CI 95% [-4016; +8949].
Conclusions: The no-lyse no-wash whole blood microvolume method for measuring mHLA-DR expression allows for simplified sample preparation without compromising accuracy of the data. This method may simplify immune monitoring of critically ill patient by the deployment of a point of care method.
Keywords: HLA-DR; flow cytometry; immunosuppression; monocytes; sepsis.
© 2023 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals LLC on behalf of International Clinical Cytometry Society.
References
REFERENCES
-
- Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 1, 307-310.
-
- Conway Morris, A., Datta, D., Shankar-Hari, M., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A., Warner, N., Judge, K., Keenan, J., Wang, A., Burpee, T., Brown, K. A., Lewis, S. M., Mare, T., Roy, A. I., Hulme, G., Dimmick, I., … Walsh, T. S. (2018). Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Medicine, 44, 627-635.
-
- de Roquetaillade, C., Dupuis, C., Faivre, V., Lukaszewicz, A. C., Brumpt, C., & Payen, D. (2022). Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: Relation with secondary infections. Annals of Intensive Care, 12, 39.
-
- Demaret, J., Walencik, A., Jacob, M.-C., Timsit, J.-F., Venet, F., Lepape, A., & Monneret, G. (2013). Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry, 84B, 59-62.
-
- Döcke, W.-D., Höflich, C., Davis, K. A., Röttgers, K., Meisel, C., Kiefer, P., Weber, S. U., Hedwig-Geissing, M., Kreuzfelder, E., Tschentscher, P., Nebe, T., Engel, A., Monneret, G., Spittler, A., Schmolke, K., Reinke, P., Volk, H.-D., & Kunz, D. (2005). Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: A multicenter standardized study. Clinical Chemistry, 51, 2341-2347.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
